Related references
Note: Only part of the references are listed.Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J. Douxfils et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
E. Touze et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the rubber effect
Panayiotis D. Ziakas et al.
PLOS ONE (2018)
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Robert C. Gosselin et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations
I. H. Jaffer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system
Kevin P. Bliden et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Laboratory Assessment of Direct Oral Anticoagulants
Jonathan Douxfils et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors
Elizabeth M. Van Cott et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
James D. Douketis et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients
Gary W. Moore et al.
BLOOD COAGULATION & FIBRINOLYSIS (2016)
Estimation of dabigatran plasma concentrations in the perioperative setting An ex vivo study using dedicated coagulation assays
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Performance of Various Laboratory Assays in the Measurement of Dabigatran in Patients Receiving Therapeutic Doses A Prospective Study Based on Peak and Trough Plasma Levels
Robert Gosselin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Measuring Dabigatran Concentrations Using a Chromogenic Ecarin Clotting Time Assay
Robert C. Gosselin et al.
ANNALS OF PHARMACOTHERAPY (2013)
Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels
E. M. Hawes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Ecarin modified rotational thrombelastometry: a point-of-care applicable alternative to monitor the direct thrombin inhibitor argatroban
Eva Schaden et al.
WIENER KLINISCHE WOCHENSCHRIFT (2013)
Dabigatran Effects on the International Normalized Ratio, Activated Partial Thromboplastin Time, Thrombin Time, and Fibrinogen: A Multicenter, In Vitro Study
William E. Dager et al.
ANNALS OF PHARMACOTHERAPY (2012)
Impact of dabigatran on a large panel of routine or specific coagulation assays Laboratory recommendations for monitoring of dabigatran etexilate
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Joanne van Ryn et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects
Joachim Stangier et al.
CLINICAL PHARMACOKINETICS (2008)
Drug Monitoring of Argatroban Using the Ecarin Chromogenic Assay
Goetz Nowak et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
Joachim Stangier et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients:: a population model analysis
Karl-Heinz Liesenfeld et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Comparing direct thrombin inhibitors using aPTT ecarin clotting times, and thrombin inhibitor management testing
RC Gosselin et al.
ANNALS OF PHARMACOTHERAPY (2004)
Correlation of point-of-care ecarin clotting time versus activated clotting time with Bivalirudin concentrations
L Cho et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants
GW Moore et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
The ecarin clotting time, a universal method to quantify direct thrombin inhibitors
G Nowak
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Ecarin chromogenic assay - A new method for quantitative determination of direct thrombin inhibitors like hirudin
U Lange et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Methods for the monitoring of direct thrombin inhibitors
G Hafner et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Hirudin determination in plasma can be strongly influenced by the prothrombin level
E Lindhoff-Last et al.
THROMBOSIS RESEARCH (2000)
Share Paper
